Has Hardik Patel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $178 in general payments to Hardik Patel, MD across 6 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Hardik Patel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Hardik Patel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Hardik Patel, MD

Internal Medicine · The Villages, FLNPI 1609430727

Payments from drug & device makers

$178in general payments, 2019–2025

Across 6 payments — averaging $29.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Zimmer Biomet$102
AstraZeneca$40
Smith+Nephew$23
Amgen$13

What the payments were for

Food & beverage$178100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Zimmer Biomet	2	$102
AstraZeneca	2	$40
Smith+Nephew	1	$23
Amgen	1	$13

How this compares

$178 in reported general payments places this provider in the 35th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Medicare billing

Part B allowed, 2024

$233,604

Medicare patients

868

Services billed

2,619

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	81	$103,887
OzempicSemaglutide	19	$45,852
JardianceEmpagliflozin	25	$23,135
XareltoRivaroxaban	12	$16,483
Repatha SureclickEvolocumab	13	$8,169
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	16	$3,940
Atorvastatin Calcium	273	$3,216
Gabapentin	58	$2,458
Clobetasol Propionate	18	$2,448
Diltiazem 12hr ErDiltiazem Hcl	12	$2,420
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	13	$2,290
Levothyroxine Sodium	155	$2,035
Methylprednisolone	266	$2,003
Metoprolol Succinate	95	$1,701
Albuterol Sulfate HfaAlbuterol Sulfate	35	$1,487

Paid to pharmacies, not to this prescriber.

Other internal medicine in The Villages

Yaneicy Gonzalez RojasCoral Gables$93.5M
Juan Carlos RondonHollywood$66.8M
Jaynier MoyaPembroke Pines$45.4M
Mark KutnerMiami$35.7M
Gilberto JimenezHialeah$35.6M
Mira BaronWest Palm Beach$29.6M
William SanchezHialeah$28.9M
Nelia Sanchez-CrespoHollywood$28.8M
Kwabena AyesuOrlando$27.6M
Michael DeverWindermere$24M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →